<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643564</url>
  </required_header>
  <id_info>
    <org_study_id>1111M06547</org_study_id>
    <nct_id>NCT01643564</nct_id>
  </id_info>
  <brief_title>Cytokine Profiling Post-Heart Transplant</brief_title>
  <official_title>Cytokine Profiling of Cardiac Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Measurement of cytokine levels in post-cardiac transplant patients with unexplained graft&#xD;
      dysfunction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Subject Recruitment&#xD;
  </why_stopped>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection</measure>
    <time_frame>12 months</time_frame>
    <description>Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">34</enrollment>
  <condition>Cardiac Transplant</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Heart Transplant Recipients with Unexplained Graft Dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Normal Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Class III-IV Heart Failure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <description>Heart Transplant Recipients with Normal Graft Function</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiology Clinic and inpatient service. Normal controls are volunteers from within the&#xD;
        community.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Group 1&#xD;
&#xD;
          -  18 years and older&#xD;
&#xD;
          -  Cardiac Transplant recipient with graft dysfunction of unknown etiology&#xD;
&#xD;
        Group 2&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  No history of heart failure or cardiac transplantation Group 3&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Class II-IV heart failure Group 4&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Heart Transplant 6 months or greater prior to blood draw&#xD;
&#xD;
          -  No graft dysfunction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Group 1 Heart Transplant with Unexplained Graft Dysfunction&#xD;
&#xD;
          -  Cellular or antibody-mediated cardiac allograft dysfunction&#xD;
&#xD;
        Group 2 Normal Control group&#xD;
&#xD;
          -  Active infection within 1 month of blood draw&#xD;
&#xD;
          -  Known Inflammatory Disease&#xD;
&#xD;
        Group 3 Heart Failure Group&#xD;
&#xD;
          -  Active infection within 1 month of blood draw&#xD;
&#xD;
          -  Known Inflammatory Disease&#xD;
&#xD;
        Group 4 Heart Transplant with Normal Graft Function Group&#xD;
&#xD;
          -  Active infection within 1 month of blood draw&#xD;
&#xD;
          -  Known graft dysfunction&#xD;
&#xD;
          -  Known Inflammatory Disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter M Eckman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>July 16, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2012</study_first_posted>
  <last_update_submitted>January 6, 2014</last_update_submitted>
  <last_update_submitted_qc>January 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transplant</keyword>
  <keyword>Cytokines</keyword>
  <keyword>Graft Dysfunction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

